Neurons and cancer cells use glucose extensively, yet the precise advantage of this adaptation remains unclear. These two seemingly disparate cell types also show an increased regulation of the apoptotic pathway, which allows for their longterm survival 1 . Here we show that both neurons and cancer cells strictly inhibit cytochrome c-mediated apoptosis by a mechanism dependent on glucose metabolism. We report that the pro-apoptotic activity of cytochrome c is influenced by its redox state and that increases in reactive oxygen species (ROS) following an apoptotic insult lead to the oxidation and activation of cytochrome c. In healthy neurons and cancer cells, however, cytochrome c is reduced and held inactive by intracellular glutathione (GSH), generated as a result of glucose metabolism by the pentose phosphate pathway. These results uncover a striking similarity in apoptosis regulation between neurons and cancer cells and provide insight into an adaptive advantage offered by the Warburg effect for cancer cell evasion of apoptosis and for long-term neuronal survival.
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Apoptosis is a genetically regulated process that is essential for the development of the organism, but its dysregulation can lead to neurodegenerative disorders as well as cancer 2, 3 . A crucial event in the apoptotic pathway is the release of cytochrome c from the mitochondria. In healthy cells, cytochrome c resides in the mitochondrial intermembrane space where it serves as a redox carrier for the electron transport chain. However, in response to many apoptotic stimuli, cytochrome c is released into the cytosol where it can initiate the formation of the apoptosome complex, leading to caspase activation and subsequent cell death 4 . Emerging evidence indicates that cells, such as postmitotic neurons, that last the lifetime of the organism, as well as cancer cells, which must overcome a cell death response, inhibit the apoptotic pathway 1 . Interestingly, despite the striking morphological and functional differences between neurons and cancer cells, both extensively metabolize glucose 5, 6 . Here we examined whether the reliance on glucose metabolism was important for the increased resistance to apoptosis in neurons and cancer cells.
We assessed the ability of endogenous cytochrome c to activate apoptosis in sympathetic neurons by using a truncated form of the pro-apoptotic protein Bid (tBid). Full-length Bid is cleaved intracellularly into tBid in response to certain apoptotic stimuli, where it then acts as a potent inducer of cytochrome c release from mitochondria 7 . Expression of tBid-GFP plasmid DNA in mouse embryonic fibroblasts (MEFs) resulted in rapid and complete apoptosis, but sympathetic neurons maintained in nerve growth factor (NGF) were resistant to expression of tBid-GFP ( Fig. 1a, Supplementary Information, Fig. S1 ). Sympathetic neurons are known to be resistant to microinjections of exogenous cytochrome c because of the inhibition of caspases by XIAP. In contrast to wild-type neurons, XIAP-deficient sympathetic neurons are sensitive to microinjection of excess exogenous cytochrome c 8 . However, we were surprised to find that the release of endogenous cytochrome c with tBid was incapable of inducing apoptosis even in XIAP-deficient neurons ( Fig. 1b ). Although it did not induce apoptosis, tBid was completely capable of releasing cytochrome c in these neurons ( Fig. 1c ; Supplementary  Information, Fig. S2a ). Similarly, injection of a Bid BH3 peptide in neurons induced the release of cytochrome c from mitochondria but this did not result in death (Supplementary Information, Figs S1c, S2b). Interestingly, despite having released cytochrome c, these neurons maintain their mitochondrial membrane potential ( Supplementary  Information, Fig. S2c ) 9 . Thus, in NGF-maintained neurons, the release of endogenous cytochrome c was incapable of inducing apoptosis even in the absence of XIAP ( Supplementary Information, Fig. S3 ). To focus on this unexpected XIAP-independent mechanism of post-cytochrome c regulation, we conducted all following experiments in neurons isolated from XIAP-deficient mice.
Despite the resistance of neurons to death following cytochrome c release by tBid, sympathetic neurons readily undergo cytochrome c-mediated cell death in response to multiple apoptotic stimuli 10, 11 . Thus, apoptotic stimuli must render endogenous cytochrome c capable of activating apoptosis in neurons. Indeed, NGF deprivation, as well as DNA damage with etoposide, sensitized sympathetic neurons to apoptosis induced by tBid-mediated cytochrome c release ( Fig. 1d ; Supplementary Information, Figs S1b, c, S4a). As tBid may cause the release of multiple factors from the mitochondria, we examined whether this observed effect was a direct result of sensitization to cytochrome c. Indeed, NGF-deprived or DNA-damaged neurons injected with cytochrome c (at a time-point before endogenous cytochrome c release) also showed increased sensitivity ( Fig. 1e ; Supplementary Information, Fig. S4b ).
To be apoptotically active, cytochrome c must exist as a holoenzyme complete with its haem prosthetic group 12 . In vitro studies have examined whether the redox state of cytochrome c affects its apoptotic activity. Some studies show that oxidized cytochrome c is more apoptotically active, but others suggest that the reduced form is also functional [13] [14] [15] [16] [17] [18] [19] . In particular, a recent study showed that oxidation of cytochrome c by cytochrome c oxidase promotes caspase activation, whereas its reduction by tertamethylphenylenediamine blocks caspase activation 18 . Similarly, oxidized but not reduced cytochrome c was found to promote apoptosis in permeabilized HepG2 cells 19 . To determine whether the intracellular redox environment affects the sensitivity of intact neurons to cytochrome c, we treated neurons with either low levels of hydrogen peroxide (H 2 O 2 ) to create a more oxidized environment, or cell-permeable reduced glutathione (GSH) to simulate a reduced environment. A high death rate was observed for neurons injected with cytochrome c (2.5 μg μl -1 ) only 10-16 h after injection ( Fig. 2a, b ). However, H 2 O 2 greatly increased the sensitivity of neurons to injected cytochrome c ( Fig. 2a ), whereas neurons treated with GSH were resistant ( Fig. 2b) . These results show that in intact cells, the redox environment has a marked affect on the ability of cytochrome c to promote apoptosis.
As changes in the redox environment can have widespread effects, we determined whether the ability of the reduced cellular environment to inhibit cytochrome c-mediated apoptosis is a result of the specific inactivation of cytochrome c. Incubation of exogenous cytochrome c (which is predominantly oxidized) with cytochrome c reductase or dithiothreitol rendered this now reduced cytochrome c ( Supplementary Information, Fig. S7a ) less effective in promoting apoptosis of injected neurons ( Fig. 2c, d ). Thus, oxidized cytochrome c was a more potent inducer of apoptosis than reduced cytochrome c. In addition, we generated an N52I mutant of cytochrome c, which has increased stability 20 . The redox status of this protein in intact cells is unclear; however, injection of the N52I mutant cytochrome c into sympathetic neurons induced significantly less apoptosis than did wild-type cytochrome c ( Supplementary Information, Fig. S5 ). Two predictions may be made on the basis of the observation that cytosolic cytochrome c requires an oxidized cellular environment to be pro-apoptotic. First, the ability of tBid-induced cytochrome c release to promote apoptosis in MEFs but not in NGF-maintained neurons may be due to a marked difference in their redox environment. Consistent with this, we found that the average intensity of the redox-sensitive dye 5-(and-6)-chloromethyl-2´, 7´-dichlorodihydrofluorescein diacetate (CM-H 2 DCFDA) was 5-fold less in sympathetic neurons, compared with MEFs, indicating reduced levels of reactive oxygen species (ROS) in sympathetic neurons ( Supplementary Information, Fig. S6a ). Second, NGF deprivation, which sensitizes neurons to cytochrome c-induced death, may result in an increased oxidized cellular environment. It is known that the cellular redox status of cells can change during apoptosis 21 . Indeed, ROS intensity, as measured by CM-H 2 DCFDA and dihydrorhodamine (DHR), was increased more than 2.5-fold after NGF deprivation in neurons ( Supplementary Information, Fig. S6b, c) 22, 23 . This increase in ROS following NGF deprivation was important to permit cytochrome c-mediated apoptosis, as addition of GSH completely inhibited the ability of NGF deprivation to sensitize neurons to cytochrome c release by tBid ( Fig. 2e ). Importantly, we examined whether there was a difference in the ability of NGF-maintained versus NGF-deprived lysates to affect the redox state of cytochrome c. As anticipated, although oxidized cytochrome c remained oxidized in NGF-deprived lysates, it was rapidly reduced on incubation with NGF-maintained neuronal lysates ( Fig. 2f) . Similarly, addition of reduced cytochrome c resulted in its oxidation in NGF-deprived, but not NGF-maintained neuronal lysates (Supplementary Information, Fig. S7b ), indicating that cytosolic cytochrome c would exist in a different redox state in NGF-maintained, healthy neurons, compared with those undergoing apoptosis in response to NGF deprivation.
GSH is one of the most prevalent intracellular reducing agents and maintains redox homeostasis by scavenging ROS. We found that endogenous GSH is necessary for maintaining cytochrome c in an inactive state in NGF-maintained neurons, as removal of GSH with diethyl maleate (DEM) or inhibition of GSH synthesis by buthionine-sulfoximine (BSO) leads to an increase in ROS 22 and sensitizes cells to cytosolic cytochrome c ( Fig. 3a, b ; Supplementary  Information, Fig. S8a ). Levels of GSH are maintained in cells by reduced nicotinamide adenine dinucleotide phosphate (NADPH), which is generated when glucose is metabolized by the pentose phosphate pathway 24 . We examined whether the pentose phosphate pathway was important for regulating the redox status of neurons, and thus cytochrome c-mediated apoptosis. Neurons treated with the pentose phosphate pathway inhibitors dehydroepiandrosterone (DHEA) or 6-anicotinamide (6-AN) accumulated high levels of ROS and became sensitive to endogenous cytochrome c release with tBid ( Fig. 3c, d ; Supplementary Information, Fig. S8b ). This effect was not unique to neurons derived from the superior cervical ganglia, as sensory neurons from the dorsal root ganglia (DRG) were also resistant to cytochrome c release by tBid, but became sensitive after DHEA treatment ( Supplementary Information, Fig. S9 ). Together, these data show that glucose metabolism by the pentose phosphate pathway promotes neuronal survival by maintaining GSH levels and directly restricting cytochrome c-mediated apoptosis. As with neurons, many cancer cells are known to metabolize glucose extensively, a phenomenon known as the Warburg effect 6 . To investigate whether increased glucose metabolism in cancer cells directly regulates apoptosis at the level of cytochrome c, we first examined the sensitivity of cancer cells to cytosolic injection of cytochrome c. Cytochrome c was injected in the presence of Smac to eliminate the activity of IAPs that are known to block caspase activation in many cancer cells 25 , thus focusing on IAP-independent mechanisms of cytochrome c regulation. Normal cells readily underwent apoptosis in response to cytosolic cytochrome c, whereas cancer cells showed an increased resistance ( Fig. 4a ; Supplementary Information, Fig. S10a ). The decreased sensitivity to cytochrome c correlated well with the increased levels of intracellular GSH found in these cancer cells (Fig. 4b) . Interestingly, treatment of MEFs with cell-permeable GSH increased their resistance to cytosolic cytochrome c (Fig. 4c ). In addition, although incubation of oxidized cytochrome c with MEF lysate did not significantly affect the redox state of oxidized cytochrome c, oxidized cytochrome c was rapidly reduced on incubation with lysates generated from cancer cells (Fig. 4d ).
We next examined whether enhanced glucose metabolism through the pentose phosphate pathway in HeLa and JM2 cancer cells contributes to cellular redox homeostasis, and thus resistance to cytochrome c. Indeed, addition of the pentose phosphate inhibitor DHEA increased ROS levels and specifically rendered these cancer cells sensitive to cytosolic cytochrome c (Fig. 4e, f; Supplementary Information,  Fig. S10b ). Importantly, glucose deprivation also resulted in a similar increase in sensitivity to cytochrome c (Fig. 4g ). Together, these results show that the ability of cytochrome c to induce apoptosis is strictly regulated by its redox state and that glucose flux is a critical regulator of cytochrome c-mediated apoptosis.
By coupling the pro-apoptotic activity of cytochrome c to the pentose phosphate pathway, cells in which glucose metabolism is increased, such as neurons and cancer cells, are able to effectively maintain a restrictive environment for cytochrome c-mediated apoptosis. Such a regulation would be physiologically important for neurons that have limited regenerative potential and survive long-term, and advantageous to cancer cells in evading apoptosis. Flux through the pentose phosphate pathway is likely to inhibit apoptosis under various conditions. For example, upregulation of TIGAR following p53 activation by DNA damage was recently shown to engage the pentose phosphate pathway and promote cell survival 26 . Overexpression of glucose-6-phosphate dehydrogenase was also shown to promote tumour formation by increasing GSH through pentose phosphate pathway 27 . Our results suggest that a specific mechanism by which this could inhibit apoptosis is through direct inactivation of cytochrome c.
Although maintenance of redox homeostasis is a primary function of the pentose phosphate pathway, flux through this pathway may also inhibit apoptosis at other levels. For example, NADPH production through the pentose phosphate pathway maintains caspase-2 in an inactive state in Xenopus laevis egg extracts by a mechanism independent of GSH synthesis 28 .
Neurons undergoing cytochrome c-mediated apoptosis must overcome multiple blocks to undergo cell death. We have shown previously that endogenous XIAP is a potent inhibitor of cytochrome c-mediated apoptosis in neurons 8 , and here, that endogenous cytochrome c itself is incapable of inducing apoptosis in NGF-maintained neurons. In response to developmental apoptosis after trophic factor deprivation, these neurons not only showed degradation of XIAP to allow for caspase activation, but also a marked decrease in glucose uptake 29 and increase in ROS ( Supplementary Information, Fig. S6b, c) 8, 22, 23 , which our results show is essential for the activation of cytochrome c, and thus, apoptosis.
Increases in intracellular ROS as well as mitochondrial damage are commonly seen during ageing and are associated with apoptotic cell death in many neurodegenerative diseases, including Parkinson's disease 30, 31 . Our results provide mechanistic insight into how even a modest increase in ROS can prime neurons to undergo apoptosis in response to otherwise potentially non-lethal events of mitochondrial damage and cytochrome c release.
Neurons and cancer cells are indeed strikingly distinct by most criteria. Different cancer cells themselves appear to inhibit the apoptotic pathway at different points. However, these results bring into focus the possibility that multiple mechanisms evolved by neurons to restrict apoptosis would be similar to those adapted by some mitotic cells during their progression to becoming cancerous.
METHODS

Reagents.
All reagents were purchased from Sigma or Fisher Scientific, unless otherwise stated. Collagenase and trypsin were purchased from Worthington Biochemical Corporation. The GSH:GSSG kit was purchased from Calbiochem. Horse cytochrome c was purchased from Sigma. zVADfmk was purchased from Enzyme Systems. Annexin V-FITC was purchased from R&D Systems. Recombinant Smac protein was purified from bacteria as described previously 8 NC). Sk-Mel 103 cells were a gift from Channing Der (UNC, Chapel Hill, NC). XIAP -/mice were a gift from Craig Thompson (University of Pennsylvania, Philadelphia, PA).
Sympathetic neuronal cultures.
Primary sympathetic neurons were dissected from the superior cervical ganglia of postnatal day 0-1 mice (wild-type ICR or XIAP-deficient C57BL/6 mice) and maintained in culture as described previously 8 . Cells were plated on collagen-coated dishes at a density of 10,000 cells per well. Neurons were grown for 4-5 days in NGF-containing medium before subjecting them to experimental conditions. For NGF deprivation, cultures were rinsed three times with medium lacking NGF, followed by the addition of goat anti-NGF neutralizing antibody. Cells were treated with various compound: etoposide (20 μM); DHEA (200 μM), 6-AN (0.1 mM); DEM (0.1 mM); GSHethyl ester (10 mM); BSO (200 μM).
Microinjection and quantification of cell survival. Cells were injected with horse cytochrome c protein (2.5 μg μl -1 ) or Bid BH3 peptide (8 mM) (AnaSpec) and rhodamine dextran (4 μg μl -1 ) in microinjection buffer containing 100 mM KCl and 10 mM KPi, pH 7.4 as described previously 8 . Immediately after injections, the number of rhodamine-positive cells were counted. At various times after injections, the number of viable injected cells remaining was determined using the same counting criteria and expressed as a percentage of the original number of microinjected cells. This method of assessing survival correlates well with other cell-survival assays, such as trypan blue exclusion and staining with calcein AM 8 .
In experiments involving microinjection of DNAs, 100 ng μl -1 of the tBid expressing plasmid, or EGFP vector in microinjection buffer was injected into the nucleus of neurons or MEFs. To quantify survival after injection, GFP-positive cells were counted 5 and 24 h after injection. Cell survival is expressed as a ratio of viable GFP-positive cells at 24 h post-injection to GFPpositive cells at 5 h post-injection. As tBid rapidly induces death (under certain conditions), the window between detectable expression of tBid-GFP in cells and apoptosis is narrow. Therefore, we chose an early time-point for time zero, to avoid excluding cells that may die soon after this. Under conditions where injection of tBid-GFP or GFP alone does not kill cells, this number becomes greater than 100% as a few additional cells begin to express visible GFP after the initial count. Under conditions where cell death occurred, death was confirmed as caspase-dependent as it could be inhibited with zVAD-fmk (50 μM). Cell survival was also assessed by annexin-V positivity, according to the manufacturer's protocol.
Immunofluorescence microscopy for assessing cytochrome c release. The status of cytochrome c (whether intact in the mitochondria or released) was examined by immunofluorescence microscopy. Sympathetic neurons show a punctate mitochondrial staining with anti-cytochrome c antibody, which is lost as cytochrome c is released from the mitochondria. Briefly, cultured sympathetic neurons were fixed in 4% paraformaldehyde and incubated overnight with anti-cytochrome c (1:1000; 556432, BD Biosciences), or anti-GFP (1:100; Cell Signaling) primary antibody followed by a 2 h incubation with anti-mouse Cy3 (1:400), anti-mouse Alexa 488 (1:1000) or anti-chicken Alexa 488 (1:1000) secondary antibody (Jackson Labs). Nuclei were stained with Hoechst 33258 (Molecular Probes).
ROS measurement.
The redox-sensitive dye CM-H 2 DCFDA or dihydrorhodamine (DHR) (Molecular Probes) was used to measure ROS levels in sympathetic neuronal cultures and cell lines using the protocol described previously 22 . CM-H 2 DCFDA is non-fluorescent when reduced and after cell permeabilization, is cleaved by esterases and trapped in the cell where oxidation converts it to a fluorescent form. After treatment of cells with various experimental conditions, cells were incubated with 10 μM CM-H 2 DCFDA or 10 μM DHR for 20 min then rinsed three times in PBS. Fluorescent intensity of cells was represented as an image, and/or quantified by measuring pixel intensity in a 50 μm 2 area within individual soma using Metamorph software or by measuring the fluorescence intensity using a Fluoroskan (ThermoLabSystems) plate reader.
Preparing reduced cytochrome c, and assessing cytochrome c redox status. Cytochrome c was reduced by incubating it with 10 U ml -1 of cytochrome c reductase (NADPH) followed by injection into neurons. Alternatively, cytochrome c was reduced with 0.5 mM DTT, then separated on PD-10 columns (GE Healthcare). The redox status of cytochrome c was assessed by monitoring its absorbance at 550 nm on Nanodrop spectrophotometer. For experiments involving analysis of redox activity of cytochrome c after NGF deprivation, sympathetic neurons were plated at a density of 100,000 cells and maintained in NGF or deprived of NGF for 12 h. Neuronal lysate was collected and incubated with oxidized cytochrome c (10 μM) for 15 min before analysis, as described above. For mitotic cells, oxidized cytochrome c (10 μM) was incubated with cell lysates (200 μg) for 15 min before measurement at 550 nm.
Reduced glutathione measurements. Measurements of GSH:GSSG were carried out using the GSH:GSSG ratio kit according to a modified version 32 of the manufacturer's. Briefly, cells were lysed in 5% metaphosphoric acid for 15 min, centrifuged and the GSH content of the supernatant was measured by the rate of colorimetric change of 5,5´-dithiobis(nitrobenzoic acid) at 412 nm in the presence of glutathione reductase and NADPH. The acid pellet was resuspended in 1 N NaOH and the solubilized protein concentration measured by the Lowry method (BioRad). Total GSH is represented as ng of GSH per µg of cellular protein. 
